ChemoCentryx (CCXI) Misses Q2 EPS by 2c

ChemoCentryx (NASDAQ: CCXI) reported Q2 EPS of ($0.56), $0.02 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $1.81 million versus the consensus estimate of $4.85 million.

For earnings history and earnings-related data on ChemoCentryx (CCXI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c